Therapeutic targeting of SARS-CoV-2 using LNA-modified antisense oligonucleotides for the treatment of COVID-19 patients with acute respiratory disease
Related Posts
November 21, 2023 |
New York, New York – The Science Philanthropy Alliance congratulates Philanthropist and Caltech Alumnus Ross Brown on his generous gift of $400 […]
November 7, 2023 |
When deciding which areas to support, funders have often asked, “How do we stay at the cutting edge of science […]